CPT temporary-codes-q0035-q9999 Reimbursement & Policy Analysis

HCPCS-Q4278-EPIEFFECT-PER-SQ-CM-TOPICAL-DERMAL-TREATMENT

HCPCS Level II Q4278: Epieffect, Per Square Centimeter

HCPCS-Q4321-RENOGRAFT-PER-SQ-CM-ADD-ON

HCPCS Q4321: Renograft, per square centimeter (add-on)

HCPCS-Q9004-VA-WHOLE-HEALTH-PARTNER-SERVICES

HCPCS Q9004: Department of Veterans Affairs Whole Health Partner Services

HCPCS-Q5144-ADALIMUMAB-AACF-IDACIO-INJECTION-1MG

HCPCS Q5144: Adalimumab‑aacf (Idacio) Injection, 1 mg

HCPCS-Q4202-KEROXX-OPHTHALMIC-VISCOELASTIC-1CC

HCPCS Level II Q4202: Keroxx (2.5g/cc) 1cc

HCPCS-Q2049-DOXORUBICIN-LIPOSOMAL-LIPODOX-10MG-INJECTION

HCPCS Q2049: Doxorubicin Hydrochloride Liposomal (Lipodox), 10 mg Injection

HCPCS-Q4295-AMNIO-TRI-CORE-AMNIOTIC-GRAFT-PER-SQ-CM

HCPCS Level II Q4295: Amnio Tri-Core Amniotic Graft, Per Sq Cm

HCPCS-Q0513-PHARMACY-DISPENSING-INHALATION-DRUG-30-DAY

HCPCS Q0513: Pharmacy Dispensing Fee for Inhalation Drug(s), 30 Days

HCPCS-Q4367-AMNIOCORE-SL-AMNIOTIC-MEMBRANE-PER-CM2

HCPCS Q4367: Amniocore SL, Amniotic Membrane per cm2

HCPCS-Q0237-TOCILIZUMAB-ANOH-HOSPITALIZED-COVID19-INJECTION-1MG

HCPCS Q0237: Tocilizumab-anoh Injection for Hospitalized Adults with COVID-19